Concepedia
Statistics
Publications
8
Citations
615
H-Index
Active since
1999
Affiliations
Harvard University(Current)
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Hubrecht Institute for Developmental Biology and Stem Cell Research
University Medical Center Utrecht
André A. F. L. van Puijenbroek is an author at Harvard University specializing in medicine, cell signaling, and cell biology.
Top concepts
MedicineCell SignalingCell BiologySignal TransductionImmunologyTumor BiologyCell PhysiologySystems BiologyCell DeathAutoimmunity
Publications per year
1999–2011
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells
Dimitrios Tzachanis, Gordon J. Freeman, Naoto Hirano et al. · Nature Immunology · 2001 · 274 citations
Signal Transduction, Negative Regulator, T-regulatory Cell +9
CD28 Costimulation Mediates Down-Regulation of p27<i>kip1</i> and Cell Cycle Progression by Activation of the PI3K/PKB Signaling Pathway in Primary Human T Cells
Leonard J. Appleman, André A. F. L. van Puijenbroek, Kirstin M. Shu et al. · The Journal of Immunology · 2002 · 197 citations · Full text
cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression
Thomas Grader‐Beck, André A. F. L. van Puijenbroek, Lee M. Nadler et al. · Blood · 2003 · 49 citations · Full text
PHOSPHOLIPASE A2INHIBITORS AND LEUKOTRIENE SYNTHESIS INHIBITORS BLOCK TNF-INDUCED NF-κB ACTIVATION
André A. F. L. van Puijenbroek, Sacha Wissink, Paul T. van der Saag et al. · Cytokine · 1999 · 34 citations
Inflammation, Cytokine, Anti-inflammatory +8
Functional microRNA screening using a comprehensive lentiviral human microRNA expression library
Jos B. Poell, Rick J. van Haastert, Francesco Cerisoli et al. · BMC Genomics · 2011 · 21 citations · Full text
1–5 of 8